Polymyxins are potent antibiotics that bind to the outer membrane of Gram-negative bacteria, entering the cell and disrupting the inner membrane, resulting in cell death. They were traditionally used as antibiotics of last resort, but the recent surge of multidrug resistant pathogens has renewed interest in these antibiotics. The emergence of polymyxin resistance determinants such as the recently discovered plasmid-mediated phosphoethanolamine transferase MCR-1 may put a strain on the future effectiveness of this antibiotic. One method to combat the rise in antibiotic resistant bacteria is through the identification and development of antibiotic adjuvants. These are small molecules that are able to inhibit the resistance mechanism, allowing previously ineffective antibiotics to once again become effective at treating bacterial infections. In this work, a high throughput cell-based screen was conducted using an in-house library of Actinomycete-derived crude cell extracts in order to search for a natural product inhibitor of an E. coli strain expressing mcr-1. In addition, the development of a new enzyme assay was attempted using purified MCR-1 C-terminal catalytic domain and a chromogenic substrate to test enzymatic activity in vitro, in hopes of establishing a simple means of studying inhibition of MCR-1. The structure-function relationship of MCR-1 was also explored by generating amino acid substitutions and studying their effect on the ability of the enzyme to confer resistance to colistin, as well as the generation of MCR-1 transmembrane truncation mutants to determine if it was possible to generate a shorter variant of MCR-1 that retained its enzymatic activity. This work furthers our understanding of the biochemistry and enzymology of MCR-1, and outlines attempts to identify inhibitors of MCR-1 in order to re-sensitize resistant bacteria to polymyxins. / Thesis / Master of Science (MSc) / Polymyxins are potent antibiotics that are threatened by the spread of multi-drug resistant bacteria. Resistance to these antibiotics is relatively rare, although the recent discovery of a mobile polymyxin resistance enzyme, MCR-1, threatens the future use of this antibiotic for treating infections, as it can readily transfer to other bacteria. The goal of this work was to search for a natural product inhibitor of MCR-1 in order to reverse its ability to confer resistance to polymyxins. A color-changing assay was conducted with MCR-1 in hopes of establishing a method to study the inhibition of MCR-1 in vitro. Additionally, amino acid substitutions were generated in MCR-1 to better understand how key amino acids affect enzyme function, as well as transmembrane domain truncations to determine if it was possible to create a shorter functioning variant of MCR-1.

<p dir="ltr">The Centers for Disease Control and Prevention’s 2019 Antibiotic Resistance Threats Report highlights more than 2.8 million antibiotic infections each year, with at least 35,000 deaths per annum attributed to antibiotic resistance. The CDC’s 2022 COVID-19 Impact Report emphasizes a 15% increase in hospital-acquired resistant infections between 2019 and 2020, many which are caused by Gram-negative bacteria, bacteria characterized by two encapsulating membranes. The limited treatment options for Gram-negative bacterial infections underscore the critical need for new strategies to combat these pathogens. The β-barrel assembly machinery complex (BAM) is a protein complex located in the outer membrane (OM) of Gram-negative bacteria, facilitating the folding and insertion of β-barrel outer membrane proteins (OMPs) into the OM. Inhibiting the function of this complex is lethal for Gram-negative bacteria, making BAM a significant and promising drug target.</p><p dir="ltr"><i>Fusobacterium nucleatum</i> is a Gram-negative pathogen that functions in the oral microbiome, interacting with multiple levels of biofilm colonizers. <i>F. nucleatum</i> causes oral infections and is linked to colorectal cancer, impacting treatment response and disease recurrence. The pathogenicity of <i>F. nucleatum</i> in both biofilm formation and in cancer involves OMPs whose biogenesis relies on BAM; however, BAM has not been characterized in this organism. The goal of our study here is to better understand the composition, structure, and function of BAM and its potential as a drug target for <i>F. nucleatum</i>. We first used bioinformatics analysis and proteomics to investigate the putative composition of the BAM complex in <i>F. nucleatum</i>. While the core component BamA was identified, there was a notable absence of other typical accessory proteins in this organism's genome. Therefore, we postulate that unlike other bacteria such as <i>E. coli</i> and <i>A. baumannii</i>, the biogenesis of OMPs in <i>F. nucleatum</i> is mediated solely by BamA without the need of accessory components.</p><p dir="ltr">To investigate how BamA can accomplish OMP biogenesis itself, we employed biophysical techniques to analyze the structure of <i>Fn</i>BamA. We resolved the cryo-EM structure of <i>Fn</i>BamA in complex with several Fabs which showed novel structural features not previously observed in bacteria. In these structures, <i>Fn</i>BamA was found to contain four N-terminal POTRA domains arranged in a J-shaped conformation, rather than elongated. The Fab was found to bind primarily along POTRA 3 which likely stabilizes the unique conformation of the POTRA domains. The C-terminal 16-stranded b-barrel domain was observed as an inverted dimer, with the dimer interface mediated by direct interaction of the b1 strands along the lateral seam of both barrel domains. Additionally, we determined the X-ray crystal structure of the barrel domain alone which was found as a monomer. Measurements of the barrel domain of <i>Fn</i>BamA reveal it has a different shape and size than is found in other BamA structures such as in <i>E. coli</i>. Together, these structural differences provide clues to how <i>Fn</i>BamA alone may accomplish OMP biogenesis when additional components are required in other bacteria. Our ongoing studies aim to further characterize the molecular structure and function of <i>Fn</i>BamA in conjunction with promising antibiotics and other putative BAM components if discovered.</p>

No / A library of 53 benzimidazole derivatives, with substituents at positions 1, 2 and 5, were synthesized and screened against a series of reference strains of bacteria and fungi of medical relevance. The SAR analyses of the most promising results showed that the antimicrobial activity of the compounds depended on the substituents attached to the bicyclic heterocycle. In particular, some compounds displayed antibacterial activity against two methicillin-resistant Staphylococcus aureus (MRSA) strains with minimum inhibitory concentrations (MICs) comparable to the widely-used drug ciprofloxacin. The compounds have some common features; three possess 5-halo substituents; two are derivatives of (S)-2-ethanaminebenzimidazole; and the others are derivatives of one 2-(chloromethyl)-1H-benzo[d]imidazole and (1H-benzo[d]imidazol-2-yl)methanethiol. The results from the antifungal screening were also very interesting: 23 compounds exhibited potent fungicidal activity against the selected fungal strains. They displayed equivalent or greater potency in their MIC values than amphotericin B. The 5-halobenzimidazole derivatives could be considered promising broad-spectrum antimicrobial candidates that deserve further study for potential therapeutic applications.

Bacterial infections are a major cause of morbidity and mortality in both the community and nosocomial settings, particularly among the elderly and chronically ill. Sepsis is the body’s response to antigens and toxins released by the invasive pathogenic organisms that cause infection. When infection is not effectively controlled, sepsis may develop and progress to severe sepsis and septic shock. Early diagnosis and treatment is pivotal for survival in severe sepsis and particularly, septic shock. Our research focuses on developing a novel treatment strategy for septic shock by using single, ultra-high doses of aminoglycosides. In this project, the effect of a single, ultra-high dose of gentamicin in clearing bacteria from the blood and reducing the bacterial burden in vital organs was evaluated in a rat model of E. coli (Bort strain) induced peritonitis with severe sepsis/septic shock. Serum cytokine levels and serum lactate levels were serially measured. Further, the potential adverse effects of ultra-high dosing of aminoglycoside antibiotics in a short-term (9 h) invasive study and long term (180 days) non-invasive study were assessed. Neuromuscular paralyses due to ultra-high doses of aminoglycosides were assessed. In addition, renal injury markers such as serum creatinine and urinary Neutrophil Gelatinase Associated Lipocalin (NGAL) were assayed. The auditory and vestibular function was also assessed after ultra-high dosing of aminoglycoside in the long-term study. We conclude that animals can tolerate ultra-high doses of aminoglycosides with appropriate support. Animals were under neuromuscular paralysis for 28 – 50 minutes and were on ventilator support after single ultra-high doses (80 and 160 mg/kg) of aminoglycoside antibiotics (gentamicin and tobramycin). There was no significant acute or delayed renal or ototoxicity associated with the single, ultra-high dose aminoglycoside therapy. Histology studies of the kidneys and the cochlea of single, ultra-high aminoglycoside dosed animals and untreated control animals were performed after 180 days (6 months). Results indicated that there were no morphological differences between the treated and untreated control animals. Terminal deoxy-nucleotidyl transferase dUTP nick end labeling (TUNEL) assay of kidney tissue indicated that there was no apoptosis of endothelial cells in the tubular and glomerular regions with single, ultra- high dose of aminoglycosides consistent with an absence of ultrahigh dose induced nephrotoxicity. In the septic shock model, the E. coli Bort was below the limit of detection from the blood of the animals within minutes after single, ultra-high dose aminoglycoside administration. After necropsy, bacterial load was determined from all the vital organs and peritoneal fluid (site of infection). The bacterial levels were below the detection limit from the kidneys and there was a significant reduction in bacterial counts from all the remaining organs compared to the infected control animals. A decrease in serum cytokine and serum lactate levels compared to baseline was observed after ultra-high doses of aminoglycosides in the septic shock animals. Our studies have indicated that the ultra-high dose gentamicin is well tolerated by rats. It is highly effective in clearing E. coli Bort from the blood and reducing the bacterial burden in the organs in an experimental model of bacterial peritonitis/septic shock. Further studies in larger animals such as rabbits, sheep, pigs or dogs are required to confirm these results. If these findings are replicated in larger animals, this therapy may be developed further from ‘lab to bedside’ to treat septic shock patients in intensive care units (ICUs). / October 2015

Haemophilus influenzae tipo b (Hib) é uma patógeno causador de doenças como meningite. O polissacarídeo capsular (PRP) é usado como antígeno vacinal. O alto custo da vacina provém da instabilidade do PRP. Este trabalho tem por finalidade otimizar o processo de produção do PRP. Primeiro, foi escolhido um modelo matemático para a descrição da cinética de Hib. Em seguida, foi realizado um desenho experimental para avaliar os efeitos de pH e temperatura sobre a cinética. Tanto a produtividade de PRP quanto sua massa molecular foram máximas em pH 7,1, porém em temperaturas mais altas a produtividade foi maior e a massa molecular menor. As condições otimizadas foram definidas como pH 7,1 e 30 °C. Nestas condições, a massa molecular foi cerca de 78 % maior que nas condições da literatura de 37°C e pH 7,5, com uma produção de PRP equivalente. Isto resultou em maior recuperação na primeira etapa de purificação, comprovando que a condição de cultivo otimizada pode contribuir em melhores rendimentos durante o processo e assim impactar na redução do custo final da vacina. / Haemophilus influenzae type b (Hib) is a pathogen responsible for deseases like meningitis. The capsular polysaccharide (PRP) is used as antigen in vaccines. The high cost of the vaccine is due to instability of PRP. The goal of this work is to optimize the production of PRP. First, a mathematical model was selected to describe Hib kinetics. Then, an experimental design was carried out to evaluate the effects of pH and temperature. Both PRP productivity and molecular mass were optimal in pH 7.1, but at higher temperature productivity increased and molecular mass decreased. The optimal conditions were set at pH 7.1 and 30 °C. In these conditions, the molecular mass was 78 % higher, with the same amount of PRP produced. This resulted in higher recovery at the first step of purification, ensuring that the improved conditions may contribute with processes efficiency and enable reduction of the final cost of the vaccine.

Methylobacterium mesophilicum SR1.6/6 é uma bactéria endofítica isolada de ramo de citros previamente esterilizado superficialmente. Esta bactéria possui a capacidade de associar-se com uma ampla variedade de espécies e tecidos de plantas, principalmente nas raízes, mediado pela formação de biofilme e superfícies do hipocótilo de plântulas in vitro. Este trabalho teve como objetivo o desenvolvimento e a aplicação de um modelo para o estudo in vitro da associação entre esta bactéria e plântulas de soja. Metodologias de genômica e transcriptômica foram aplicadas para a obtenção do draft genômico desta bactéria e de um amplo perfil de sequências expressas, obtidas em dois tratamentos distintos; i) células de biofilme células bacterianas aderidas às raízes das plântulas removidas por sonicação, e ii) células planctônicas células bacterianas em suspensão (i.e. interagindo somente com exsudados radiculares). Os dados genômicos obtidos por 454-pirosequenciamento resultaram em uma cobertura de 37 vezes o tamanho do genoma e geraram 242 contigs. Entre estes, 187 contigs grandes representaram 96% do genoma (tamanho estimado de 6.8 Mb), com um conteúdo GC de 69.5%. Considerando a análise da expressão gênica, um procedimento para monitorar a aderência das células bacterianas às raízes das plântulas foi realizado por meio de microscopia eletrônica de varredura de amostras de raízes coletadas durante o experimento (i.e. 24, 48 e 72h após a inoculação). As células bacterianas obtidas em cada tratamento foram inicialmente submetidas à extração de RNA total, seguida de um processo de enriquecimento de mRNA e sequenciamento por meio da tecnologia de 454-pirosequenciamento (RNA-Seq). O amplo perfil de expressão gênica obtido foi mapeado no draft genômico, resultando em um total de 1.930 clusters gênicos. Posteriormente, estes clusters foram filtrados de acordo com sua abundância e ocorrência diferencial em cada tratamento, resultando em 280 genes diferencialmente expressos. Funções relacionadas ao metabolismo de etanol/metanol, divisão celular, resposta ao estresse oxidativo, produção de sideróforos, biossíntese de peptidoglicanos e hopanóides foram induzidas nas células bacterianas aderidas às raízes das plântulas, enquanto que genes relacionados ao metabolismo essencial das células foram observados principalmente nos tratamentos controle e planctônico. Estes dados fornecem uma base para estudos relacionados a mecanismos moduladores da interação bactériaplanta, distinguindo significativamente os tratamentos biofilme e planctônico, mostrando assim que o contato físico é essencial para o sucesso da interação em estudo. Por fim, estas análises permitiram uma ampla visualização de perfis de expressão gênica desta bactéria, utilizando o draft genômico primeiramente obtido como base para o estudo desta interação com a planta hospedeira. Estudos futuros podem ser desenvolvidos visando caracterizar os mecanismos adaptativos desta bactéria, como seu metabolismo metilotrófico e outros metabolismos específicos, os quais podem dar suporte ao comportamento endofítico deste organismo. / Methylobacterium mesophilicum strain SR1.6/6 is an endophytic bacterium, which has originally been isolated from surface-sterilized healthy citrus branch. This bacterium is able to associate with a range of plant species, rather in the roots, mediated by a biofilm structure, and in hypocotyl surfaces of in vitro seedlings. The aim of the present study was the development and application of a model to study in vitro the association between this bacterium and soybean seedlings. Genomic and transcriptomic approaches were applied resulting a draft of this bacterium genome and a broad profile of mapped mRNA sequences obtained in two different treatments; i) biofilm cells root adhered bacterial cells were removed by sonication, and ii) planktonic cells bacteria cells in suspension (i.e. interacting only with root exudates). Genomic data, obtained by 454-pyrosequencing have had an average depth of 37-fold coverage of the genome and yielded 242 contigs. Among these, 187 large contigs represented 96% of the genome sequence (estimate size of 6.8 Mb) with a GC content of 69.5%. Concerning the gene expression survey, the process to monitor the adherence of bacteria cells to the roots was performed by scanning electron microscopy of roots collected along the experiment (i.e. 24, 48 and 72 hours after inoculation). Bacterial cells obtained in each treatment were firstly submitted to RNA extraction, followed by mRNA enrichment and RNA-Seq using 454-pyrosequencing technology. The broad gene expression profile obtained was mapped into the drafted genome, resulting in a total of 1.930 gene clusters. After that, these clusters were filtered according to their abundance and differential occurrence in each treatment resulting in 280 differential expressed genes. Functions related to methanol/etanol metabolism, cell division, oxidative stress response, siderophore production, peptidoglycan and hopanoid biosynthesis were induced in bacterial cells adhered to plant roots, while genes related to essential cell metabolism were observed mostly in control and planktonic treatment. Also, these data provide insights into the mechanisms modulating plant microbe-interaction, significantly distinguishing biofilm and planktonic treatment, showing that the physical contact is a crucial step on plant-microbe interactions. In conclusion, results allowed a strongly supported analysis of gene expression, based on the genome draft of an endophytic bacterium interacting with the host plant. Further studies should focus on the adaptive mechanisms present in this bacterium, like the methylotrophic lifestyle and other specific metabolisms which might support its behavior as an endophytic bacterium.

Nas últimas décadas, a incidência de infecções hospitalares causadas por bactérias Gramnegativas multidrogarresistentes (MDR) vem crescendo de maneira vertiginosa em todo o mundo, de modo que a Organização Mundial de Saúde (OMS) recentemente reconheceu essas infecções como uma preocupação mundial devido ao seu impacto negativo sobre as taxas de mortalidade intra-hospitalar e dos custos da assistência à saúde, afetando tanto os países desenvolvidos quanto os em desenvolvimento. Atualmente considera-se que a higienização das mãos, o uso racional de antimicrobianos e o isolamento de contato são as principais medidas disponíveis para contenção desse avanço. Porém, elas são apenas parcialmente efetivas e de implementação trabalhosa e onerosa. Assim, considera-se necessário o desenvolvimento de formas mais simples e eficientes paralidar com esse problema. No presente estudo, nos propusemos a avaliar o impacto da administração de um produto simbiótico a pacientes colonizados e/ou infectados por bactérias Gram-negativas MDR sobre as taxas de descolonização desses patógenos no trato digestivo. Trata-se de um ensaio clínico randomizado, duplamente cego, controlado com placebo, envolvendo 101 pacientes hospitalizados com colonização prévia por bactérias Gram-negativas MDR, demonstrada por meio de cultura seletiva de swab retal, cuja intervenção consistiu na administração oral ou enteral diária de 1010 unidades de Lactobacillus bulgaricus e 1010 unidades de Lactobacillus rhamnosus associados a fruto-oligossacarídeos durante (FOS) 7 dias. O desfecho primário do estudo foi a descolonização completa do trato digestivo posterior à intervenção, que, na análise do tipo \"intenção de tratar modificada\" foi de 16,7% (8/48) no grupo experimental e 20,7% (11/53) no grupo controle (p=0,600). Na análise \"per protocol\", a descolonização completa do trato observada foi de 18,9% (7/37) no grupo experimental e 23,3% (7/30) no grupo controle (p=0,659). Em uma análise multivariada por meio de modelo de regressão logística o uso do simbiótico não influenciou significativamente o risco de descolonização completa do trato digestivo (OR= 0,80, IC 95%= 0,28-2,27, p= 0,678). A ocorrência de eventos adversos de natureza leve a moderada foi semelhante entre os grupos: 7,55% no grupo que utilizou placebo e 6,25% no grupo sob intervenção (p= 1,000). Nenhum evento adverso grave potencialmente relacionado às medicações de estudo foi observado. Nas condições estudadas, os dados obtidos pelo estudo nos levam à conclusão de que o simbiótico estudado demonstrou-se inefetivo na descolonização do trato digestivo de pacientes previamente colonizados por bactérias Gram-negativas MDR. / In recent decades the incidence of multidrug resistant (MDR) Gram-negative nosocomial infections has been dramatically raising in the whole world. The World Health Organization (WHO) recently recognized nosocomial infections due to MDR pathogens as a global concern due to its negative impact on patients, health-care workers and health-care institutions, affecting developed countries as well as developing ones. They negatively impact in-hospital mortality and health-care related costs. Hand hygiene promotion, antibiotic stewardship and contact precautions are the main available measures to control such MDR Gram-negative organisms in hospitals. However, they are only partially effective as well as difficult to be implemented and expensive. Therefore, simpler and more effective actions are thought to be helpful and urgent. In the present study, we analyzed the impact of the administration of a symbiotic product on patients harboring Gram-negative multidrug-resistant bacteria upon the subsequent rates of decolonization of these pathogens from the gastro-intestinal tract.This is a double-blinded and placebo controlled randomized clinical trial evaluating the oral/enteral daily administration of 1010 units of Lactobacillus bulgaricusplus 1010 units of Lactobacillus rhamnosus associated with fructo-oligosacharide (FOS), or placebo, for 7 days, to 101 patients previously colonized by MDR Gram-negative bacteria, identified through selective culture of rectal swab. The primary study outcome was the rate of complete decolonization of the MDR microorganism from the gastro-intestinal tract following the intervention. In the \"modified intention to treat\" analysis, decolonization rates observed were 16.7% (8/48) in the experimental group and 20.7% (11/53) in the placebo group (p=0,600). In the \"per protocol\" analysis, decolonization rates were 18.9% (7/37) in the experimental group and 23.3% (7/30) in the placebo group (p=0,659). In a logistic regression model, symbiotic use did not produce any impact on the chance of decolonization (OR=0.80, CI95%=0.28-2.27, p=0.678). Mild to moderate adverse events occured similarly in both the placebo (7.55%) and the experimental group (6.25%), (p=1,000). No severe adverse event potentially related to the medications was detected during the study period. In the present study conditions, the results obtained lead to the conclusion that the studied symbiotic proved to be ineffective to decolonize patients harboring multidrug resistant Gram-negative bacilli.

A proteína Cpn60 faz parte de um grupo de proteínas altamente conservadas que estão envolvidas em funções celulares essenciais. camundongos BALB\\c foram imunizados com 5 ou 10 µg da proteína recombinante (Cpn60r) sozinha ou adicionada à vacina DTP sem hidróxido de alumínio (NADTP). A vacina DTP do Instituto Butantan (DTP) foi usada como controle. Foi avaliada a produção de citocinas por células esplênicas após reestímulo in vitro com a Cpn60r. Os animais foram desafiados após o protocolo de imunização. A Cpn60r sozinha ou misturada à vacina NADTP foi capaz de induzir níveis de anticorpos contra pertussis mais altos do que os induzidos pela DTP. Os níveis de IgG1 e IgG2a foram similares para todos os grupos. Pôde-se observar a produção de de IL-6 e IFN-&#947 nos grupos imunizados com Cpn60r. Os grupos imunizados com Cpn60r+NADTP apresentaram um índice de proteção entre 60 e 80% contra o desafio pela bactéria virulenta, semelhante ao grupo imunizado com DTP. A proteína Cpn60r é bastante promissora não somente como imunógeno, mas também como adjuvante. / The Cpn60 protein is a member of a group of higly conserved proteins linked to essencial cell functions. The Cpn60 was cloned, expressed and its immune response has been evaluated. BALB\\c mice were immunized with 5 or 10 µg of the recombinant protein (Cpn60r) alone or mixed with DPT vaccine without aluminum hidroxyde (NADPT). The DPT vaccine from Instituto Butantan was used as control. We evaluated the cytokines production by spleen cells after they have been reestimulated in vitro with Cpn60r. The animals were challenged after the immunization protocol. The Cpn60r alone or mixed with NADPT vaccine was able to induce higher antibodies levels than DPT. IgG1 and IgG2a levels were similar in all groups. We could detect levels of IL-6 and IFN-&#947 on groups immunized with Cpn60r. The groups immunized with Cpn60r+NADTP showed a 60 and 80% protection rate against the challenge with the live bacteria, similar to the group immunized with DPT. These results show the immune response of the recombinant protein that could be included in immunization protocols for pertussis.

Atividades antropogênicas relacionadas ao uso massivo de antibacterianos tem favorecido para que ambientes aquáticos sejam importantes locais para seleção e/ou disseminação de bactérias multirresistentes (MR). O objetivo do estudo foi monitorar a ocorrência de bactérias MRs em ambientes aquáticos públicos no estado de SP, caracterizando genótipos de resistência adquirida. Foram analisados 50 isolados de bactérias gram-negativas, recuperadas de amostras de água, sendo que 70% dos isolados apresentaram perfil de MR, identificando-se os genes blaCTX-M-2 (n= 5), blaCTX-M-9 (n= 1), blaCTX-M-15 (n= 2), blaKPC-2 (n= 3), qnrB (n= 1), oqxA (n= 3), oqxB (n= 3) e, aac(6)1b-cr (n= 7). Destaca-se a primeira detecção de A. calcoaceticus produtora de KPC-2. Ambientes aquáticos de acesso público podem ser importantes fontes para a disseminação e/ou transmissão de uma ampla variedade de espécies bacterianas MRs tanto para seres humanos como para ecossistemas associados, sendo que a presença de genótipos endêmicos sugere contaminação por esgoto doméstico e/ou hospitalar. / Anthropogenic activities related to the massive use of antibacterial has contributed to the selection and spread of multidrug-resistant (MDR) into the aquatic environment. This study aimed to monitor the occurrence of MDR bacteria in public aquatic environments, in the state of São Paulo, characterizing genotypes of acquired resistance. Of the 50 gram-negative isolates, recovered of water samples, 70% exhibited a MDR profile. Indeed, blaCTX-M-2 (n= 5), blaCTX-M-9 (n= 1), blaCTX-M-15 (n= 2)-, blaKPC-2 (n= 3)-, qnrB (n= 1)-, oqxA (n= 3)-, oqxB (n= 3)- and aac(6)-1b-cr (n = 7) genes were identified. Noteworthy is the first the detection of KPC-2-producing Acinetobacter calcoaceticus. Aquatic environments, with public access, may be important sources for the dissemination and/or transmission of a wide variety of MDR bacterial species to both humans and associated ecosystems. Moreover, the presence of endemic genotypes suggests contamination by domestic and/or hospital sewage.

As Stenotrophomonas são comumente encontradas no trato respiratório de pacientes com doenças pulmonares crônicas e também na rizosfera de plantas. Esse gênero apresenta resistência a diversos antibióticos, promove o crescimento de plantas e algumas espécies apresentam a capacidade de fixar o nitrogênio atmosférico. O Multi Locus Sequence Analysis (MLSA) é uma metodologia baseada em genes constitutivos para definição e alocação taxonômica de novas espécies. O objetivo geral do presente trabalho foi caracterizar taxonomicamente uma coleção ampla de Stenotrophomonas composta por isolados endófitos, linhagens-tipo e de referência. Para tanto, foi estabelecido um sistema de classificação e identificação de Stenotrophomonas por meio de MLSA. Foi possível através da metodologia de MLSA definir 9 novas espécies, detectar a presença de um novo gênero e estabelecer um sistema online de taxonomia para Stenotrophomonas. / The genus Stenotrophomonas is found in the respiratory treatment of patients with chronic pulmonary and also in the rizhosfera of plants. It presents resistance to several antibiotics, promotes the growth of plants and some species present the ability to fix atmospheric nitrogen. The Multi Locus Sequence Analysis (MLSA) is a methodology based on constitutive genes for definition and taxonomic allocation of new species. The general objective of the present work was to characterize a wide collection constituted by Stenotrophomonas from isolated endophytic, type and reference strains. In such a way, a system of classification and identification of Stenotrophomonas by means of MLSA was established. It was possible through the MLSA methodology to define 9 new species, to detect the presence of a new genus and to establish an online system for Stenotrophomonas taxonomy.